Cystic fibrosis-related diabetes testing in Pescorocchiano
Find health labs to test for Cystic fibrosis-related diabetes in Pescorocchiano and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Diabetes Test by Laboratorio Sabino Srl
Via Servilia, 12, 02032 Fara in Sabina RI, Italia
21.5 km
Unverified
A Diabetes Test costs €23.00
See Details
Diabetes Test by Bianalisi - Biosystem Group
Via Massa di San Giuliano, 229, 00132 Roma RM, Italia
40.4 km
Hemoglobin Test by Centro Raphael
Via Mattè Trucco, 00132 Roma RM, Italia
40.4 km
Hemoglobin Test by Salvati Diagnostica - Poliambulatorio e Laboratorio Analisi
Piazza del Mercato, 61, 05100 Terni TR, Italia
35.4 km
Diabetes Test by Eurofins Genoma
Via di Castel Giubileo, 11, 00138 Roma RM, Italia
40.4 km
Hemoglobin Test by Studio Polispecialistico Nomentano
Via Nomentana, 550, 00141 Roma RM, Italia
40.4 km
Hemoglobin Test by Filia Studio Patologia Clinica
Via Costantiniana, 28, 00188 Roma RM, Italia
40.4 km
Diabetes Test by Laboratorio Di Via Diego Angeli Srl
Via Diego Angeli, 173, 00159 Roma RM, Italia
40.4 km
Diabetes Test by Farmacia Genovesi
Via Roma, 1, 05030 Otricoli TR, Italia
37.4 km
Hemoglobin Test by Laboratorio Analisi Cliniche CE.DI.M.
Viale Partenope, 18, 00177 Roma RM, Italia
40.4 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
